Seoul Pharma Co., Ltd
018680.KQ·KOSDAQ·Healthcare
1,699.000.00 (0.00%)today
At close: Nov 5, 3:30 PM KST · May be delayed up to 20 min · KRW
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close1,699.00
Open1,738.00
Day range1,650.001,738.00
52-week range1,612.003,310.00
Off day high−2.24%
Off 52-week high−48.67%
Volume7.16K
Avg. volume (3M)7.10K
Market cap19.81B
EPS (TTM)—
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.51
Shares outstanding11.66M
Short interest—
Earnings date—
Analyst target—
Profit margin3.40%
Against its peers
Compare in full ›| 018680.KQ | 000230.KS | SOLARA.NS | 000640.KS | 001360.KS | 002720.KS | |
|---|---|---|---|---|---|---|
| Market cap | 19.81B | 65.20B | 31.04B | 600.98B | 118.87B | 70.36B |
| P/E (TTM) | — | — | 83.4 | — | — | — |
| Forward P/E | — | — | 20.5 | — | — | — |
| Price/book | — | — | 2.2 | — | — | — |
| Dividend yield | — | 1.79% | — | 1.93% | — | 0.89% |
| 1-year change | −42.01% | −52.38% | +14.61% | −15.76% | −16.75% | −20.94% |
| Today | 0.00% | +0.89% | −0.25% | +1.48% | +0.08% | −1.63% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.
Latest news
All 018680.KQ news ›South Korea's Seoul Pharma Valuation Plunges from ₩100 Billion to ₩22.5 Billion; Q Capital Partners Moves Toward Fund Extension
Q Capital Partners has decided to extend the maturity of its ₩300 billion (approximately $224.0 million) blind-pool fund "2018 QCP No. 13," raised in 2019. The market capitalization of Seoul Pharma, the fund's flagship portfolio company…
From the 4Search news index, newest first.
In the news
1mentions in 30 days
1with it in the headline
Negativesentiment
Mentioned with
People in the coverage
Most coverage from
- finance.biggo.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.